How Vimpat Can Help

Vimpat Could Be the Last Epilepsy Medicine You Ever Need to Add to Your Treatment Regimen

Vimpat offers hope for partial-onset seizure control, even for people who are taking epilepsy medicines or have taken many others in the past. Adding Vimpat has been shown to reduce the number of partial-onset seizures you could have, letting you focus less on your next seizure and more on life. Vimpat can help control even difficult-to-treat seizures, giving better seizure control to those who have struggled to find it.

Vimpat Has Been Added to Every Common Epilepsy Medicine

Vimpat has been studied in clinical trials for almost 10 years. When Vimpat was added to or used in combination with every commonly used epilepsy medicine, it was found to improve control of partial-onset seizures.

Seizures were reduced by 50% or more in many people who added Vimpat to their current medication.

People who had taken several other epilepsy medicines in the past had improved seizure control after adding Vimpat.

Grid: Keppra, Topomax, Lamictal, Triletal, Depakote, Pheobarbital, Dilantin, Tegretol, Zonegran

Next: Vimpat Works in a Different Way

Meet Breanne D., adding Vimpat since 2004

Save Now on VIMPAT

Get 14 days for free and
save up to $30 on each of
your next 12 prescriptions.

Enroll Today

Epilepsy Independence Can Be Possible

Vimpat Advantage will help
you get there.

Enroll Today

Over 800,000 people taking epilepsy medicine are still having seizures. Now there's hope for seizure control. Now there's Vimpat.

Indication

Vimpat^® (lacosamide) is a prescription medicine that is used with other medicines to treat partial-onset seizures in people 17 years of age and older with epilepsy.

Important Safety Information

Vimpat is generally well-tolerated, but may not be for everyone. Ask your healthcare provider if Vimpat is right for you.

Warnings and Precautions

Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Do not stop taking Vimpat without first talking to your healthcare provider. Stopping Vimpat suddenly can cause serious problems.

Vimpat may also cause you to feel dizzy, have double vision, feel sleepy, or have problems with coordination and walking. You should not drive, operate machinery or do other dangerous activities until you know how Vimpat affects you.

Vimpat may cause you to have an irregular heartbeat or may cause you to feel faint. Call your healthcare provider if you have a fast, slow, or pounding heartbeat, shortness of breath, feel lightheaded, or if you fainted or feel like you are going to faint.

Vimpat is classified as a federally controlled substance (C-V) due to a low potential for abuse. Keep your Vimpat in a safe place and do not give it to anyone else.

In rare cases, Vimpat may cause a serious allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. Call your healthcare provider right away if you have a skin rash or hives, fever or swollen glands that do not go away, shortness of breath, swelling of the legs, yellowing of the skin or whites of the eyes, or dark urine.

Vimpat oral solution contains aspartame, a source of phenylalanine.

Common Adverse Reactions

The most common side effects with Vimpat are dizziness, headache, nausea, and double vision. To report Suspected Adverse Reactions, contact UCB, Inc. at 866-822-0068 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see additional patient information in the Patient Medication Guide. This information does not take the place of talking with your healthcare provider about your condition or your treatment.

VIMPAT (lacosamide) tablets injection

Print
E-mail

*Indicates a required field

Recipient's Name*

Recipient's E-mail Address*